16/07/2026
WHO report highlights cancer inequalities and survival gaps in Namibia and Southern Africa
Staff Reporter
A NEW World Health Organization (WHO) report has highlighted growing cancer inequalities worldwide, revealing major disparities in prevention, diagnosis, treatment and survival outcomes, including significant differences in breast cancer survival rates among women in Namibia.
The Global Status Report on Cancer 2026: The Future We Choose Together provides a comprehensive assessment of the global cancer burden, examining trends in cancer incidence, mortality, survival, risk factors and health system responses.
The report warns that cancer is becoming an increasing global crisis, with the greatest growth in cases expected in low- and middle-income countries, where health systems continue to face challenges in providing equitable access to prevention, early detection, treatment, palliative care and survivorship services.
For Namibia, the report highlights findings from the African Breast Cancer – Disparities in Outcomes (ABC-DO) study, which shows significant differences in five-year breast cancer survival rates among racial groups.
According to the report, white women in Namibia have a five-year breast cancer survival rate of 84%, compared to 69% among mixed-race women and 45% among black women.
The report links these differences to delays in diagnosis and access to treatment. It found that the median diagnostic interval — the period between first experiencing symptoms and starting treatment — was 60 days for black Namibian women, compared to 21 days for non-black women.
Differences were also observed in treatment completion rates, with approximately 43% of non-black Namibians completing their full course of treatment, compared to about 24% of black Namibians in the dataset analysed.
The WHO report said these disparities demonstrate that cancer outcomes are influenced not only by medical advances, but also by social and economic factors affecting access to healthcare.
Across Southern Africa, the report identifies similar challenges. In South Africa, breast cancer survival differences remain evident, with five-year survival rates of 54% among mixed-race women and 46% among black women. In Zambia and Uganda, survival rates are reported at 37% and 31%, respectively.
The report also highlights challenges in cancer diagnosis, citing a Botswana study where 30% of newly diagnosed lymphoma cases were reclassified after review by reference centres, with diagnostic errors linked to poorer survival outcomes.
Despite the challenges, the report points to progress in childhood cancer care, noting Zambia’s participation in the Global Platform for Access to Childhood Cancer Medicines, which aims to improve access to essential medicines and address shortages affecting treatment.
The WHO called for stronger cancer responses through three strategic shifts: improving health system capabilities, strengthening protections against financial hardship, and ensuring better value by focusing on outcomes that matter to patients, including survival and quality of life.
The report emphasises the need for integrated, people-centred cancer care, universal health coverage, stronger monitoring systems and greater involvement of communities affected by cancer.
The Cancer Association of Namibia said the report serves as a reminder that cancer cases are increasing, but urged communities not to allow fear and misinformation to create stigma around the disease.
“While we must do all in our power to treat the disease, we should NOT allow fear and misinformation to separate us from humanity,” the association said, adding that support, care and compassion can make a significant difference for people affected by cancer.
Namibia was also recognised in the report for having one of the highest levels of domestic government investment in non-communicable diseases in Africa, with relatively lower reliance on out-of-pocket and external funding compared to many neighbouring countries.
WHO Director-General Dr Tedros Adhanom Ghebreyesus said the future of cancer control would depend on collective choices and ensuring that people with lived experience of cancer are included in decision-making.
“The future of cancer control will be shaped by the choices we make together,” he said.
Photos: WHO/Pexels